“Moderna Nearly Triples On Its Cancer Vaccine’s ‘Landmark Win,’ Merck Hits Record High”

“Moderna (MRNA) stock nearly tripled Wednesday after its Merck (MRK)-partnered cancer vaccine succeeded in a late-stage study of patients with melanoma…

Moderna stock soared 177%, closing at 174.38. That’s a three-year high. Merck stock also jumped 12.6% to 152.20, hitting a record high…”

https://www.investors.com/news/technology/moderna-stock-skyrockets-over-60-merck-jumpslate-stage-cancer-vaccine-trial-win/?src=A00220